FDA Inspection 1029784 — Horizon Pharma Inc - US Operations
The FDA completed an inspection of Horizon Pharma Inc - US Operations on June 6, 2017 in Lake Forest, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 6, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lake Forest, IL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)